Chief Financial Officer

Chief Medical Officer

Hope for Rare Pediatric Disease Voucher Reignited as House Bill Passes Committee

Amylyx Pharmaceuticals announces pricing of $175 million underwritten public offering of common stock

Amylyx 17.5M share Spot Secondary priced at $10.00

Amylyx Pharmaceuticals Prices $175 Million Common Stock Offering

Senior Director, Field Medical Affairs

Amylyx is a clinical-stage pharmaceutical company focused on developing novel therapies for high unmet needs. They are seeking a Senior Director, US Field Medical, who will lead and manage a team of Field Medical professionals to execute the medical strategy, particularly for their lead program Avexitide in post-bariatric hypoglycemia (PBH). This role involves strategic leadership, team management, and cross-functional collaboration to drive field-based medical activities and insights.

Sign up with Google

Sign in with Google